Medicsight PLC (AIM: MDST), industry leader in the development of Computer-Aided Detection (CAD) and image analysis software which assists in the early detection and diagnosis of disease, announces a new global partnership with INFINITT, one of the world's leading medical imaging and picture archiving and communication systems (PACS) companies. Combined INFINITT-Medicsight products for the detection of colorectal cancer will be distributed using INFINITT's global network of offices in six strategic countries and partners and sales channel representatives in 20 other countries worldwide.

David Sumner, Chief Executive of Medicsight, said: "I am delighted to announce this new global partnership with INFINITT, already the PACS market leader in Korea and growing rapidly in other major markets. Strategic partnerships such as this one are a key component of our strategy to build a broad base distribution channel enabling the Company to penetrate global markets quickly and thereby move into profitability."

"This is the ideal time for INFINITT to partner with Medicsight." said Sun-Joo Lee, President and CEO of INFINITT. "The partnership will enable us to bring the next generation of INFINITT solutions combined with the CAD and image analysis solutions of Medicsight to meet the demanding needs of our global customers."

Dr Se Hyung Kim, Assistant Professor, Department of Radiology, Seoul National University, also commented: "CT Colonography for the screening of colorectal cancer is now at the forefront of screening technologies for this potentially fatal disease. Partnerships such as that between Medicsight and INFINITT which deliver cutting edge 3D and CAD technologies to radiologists around the world are vital to increase the adoption of this very important and life saving technique."

Medicsight's ColonCAD™ software will be integrated into INFINITT's PACS and 3D Rapidia Virtual Colonoscopy workstations. The latter is a next-generation colorectal cancer screening tool. Integration has already commenced and a successful work-in-progress project was demonstrated at the Radiology Society of North America (RSNA) meeting in November 2007, the major radiology event of the year. Medicsight and INFINITT will work together to prepare for a 2008 global launch campaign.

For further information:
Medicsight PLC
David Sumner Tel: +44 (0)20 7605 7950
www.medicsight.com

Collins Stewart Europe Limited
Tim Mickley Tel: +44 (0)20 7523 8350
Jonny Sloan Tel: +44 (0)20 7523 8302

Media enquiries:
Abchurch Tel: +44 (0) 20 7398 7700
Ashley Tapp Tel: +44 (0) 20 7398 7718
ashley.tapp@abchurch-group.com

Stephanie Cuthbert Tel: +44 (0) 20 7398 7712
stephanie.cuthbert@abchurch-group.com
www.abchurch-group.com

Notes to editors
About Medicsight

Medicsight PLC is a UK-headquartered, research-driven, leading developer of computer-aided detection (CAD) and image analysis software for the medical imaging market. The CAD software automatically highlights suspicious areas on computerised tomography (CT) scans of the colon and lung, helping radiologists to identify, measure and analyse potential disease and early indicators of disease. Medicsight's computer-aided detection (CAD) software has been validated using one of the world's largest and most population diverse databases of verified patient CT scan data. Medicsight's ColonCAD™ and LungCAD™ software products are seamlessly integrated with the advanced 3D visualisation workstations of several industry-leading imaging equipment partners.

About INFINITT

INFINITT Co., Ltd. is one of the world's leading companies in medical imaging and information management. INFINITT, founded in 1997, develops, manufactures and markets PACS systems, 3D medical imaging workstations and imaging software that are now implemented in over 1000 medical institutions in 14 countries, making the company one of the fastest growing vendors in the global PACS industry. INFINITT is the market leader in the South Korea PACS market, and is aggressively pioneering worldwide market expansion through joint ventures in four strategic regions: Japan, China, Taiwan, and the US, with a branch office in Malaysia.

About Computer-Aided Detection

With increasingly sophisticated radiological imaging hardware such as Multi-Detector CT scanners, radiologists are facing a growing challenge in the amount of detailed patient image data that they must review for each patient examination. Some CT scan examinations generate as many as 1000 images per patient. Review of this data by the radiologist is not only time-consuming but also prone to error due to reader fatigue. CAD software can help the reviewing radiologist by analysing the image data and automatically highlighting suspicious regions of interest for closer inspection. Without CAD software some potential abnormalities or areas of disease may be overlooked. This is critical for diagnosis and the management of patient outcomes as early detection of disease greatly increases the probability of successful treatment and a positive therapeutic outcome.

About Medicsight's CAD software

Medicsight's ColonCAD™ and LungCAD™ software use an advanced CAD algorithm to analyse CT scans of the colon and lung and automatically highlight suspicious areas that may be indicators of disease. CAD may highlight areas easily overlooked by the reviewing radiologist, such as small lesions or regions that are hidden from view behind folds in the colon or normal structures and surrounding tissue in the lung.

Both CAD products seamlessly integrate with the advanced 3D visualisation platforms of industry-leading imaging equipment partners. The integrated systems provide sophisticated image viewing capabilities, including 3D reconstructed image data, with the added advantage of demonstrating automatic CAD findings to assist clinical end users in the detection and analysis of disease. This allows clinical end users to perform either a 'second read', where CAD findings are displayed to the user after completion of an initial review of the CT scan data, or a 'concurrent read' where CAD findings are displayed during the user's initial review of the original CT scan images.

Since inception, Medicsight has developed close and lasting relationships with some of the world's foremost clinicians in product related areas. This provides the Company with a wealth of clinical expertise and dedicated clinical research to support ongoing product development. Medicsight also collaborates with a number of leading academic institutions and clinical research programmes worldwide to develop the Company's comprehensive database of population diverse verified patient CT scan data, thus allowing Medicsight's products to be validated to the highest possible standards.